Genome Data Systems Inc.
- UEI
- YSQZAMD97G45
- CAGE
- 1TR50
- Primary NAICS
- 541711 Research and Development in Biotechnology
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Other
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Website
- andrewmelcher.com
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Other functions genome "phase i, topic 309, label free multivariate cancer diagnosis" | National Cancer Institute | $199,987 | |
| Microfluidic flow retardation device for tagless cancer cell analysis for metastatic potential | Department of the Army | $385,000 | |
| Lfma: microfluidics-enabled microarrays | National Institutes of Health | $292,450 | |
| 200110 ! 002572 ! 1700 ! D710F !space and naval warfare systems !N6600101C8058 !a ! N!*!n! !20010718 ! 20020118 !… | Naval Information Warfare Systems Command | $151,150 |
Quick answers
What is Genome Data Systems Inc.'s UEI?
Genome Data Systems Inc.'s Unique Entity ID (UEI) in SAM.gov is YSQZAMD97G45.
What is Genome Data Systems Inc.'s CAGE code?
Genome Data Systems Inc.'s CAGE code is 1TR50.
What is Genome Data Systems Inc.'s primary NAICS code?
Genome Data Systems Inc.'s primary NAICS code is 541711 (Research and Development in Biotechnology).
Is Genome Data Systems Inc. registered in SAM.gov?
Genome Data Systems Inc.'s SAM.gov registration expired on May 8, 2014.
What is Genome Data Systems Inc.'s most recent federal award?
Genome Data Systems Inc.'s most recent federal contract award is Other functions genome "phase i, topic 309, label free multivariate cancer diagnosis" (HHSN261201200070C), from National Cancer Institute, on September 28, 2012.
On GovTribe
See Genome Data Systems Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors